Cannabinoid receptor 1 (CB1R)-5-hydroxytryptamine receptor 2A (5HT2AR) heterodimer interface (CB1R-5HT2AR heterodimer)

The Cannabinoid receptor 1 (CB1R)-5-hydroxytryptamine receptor 2A (5HT2AR) heterodimer interface is a unique protein-protein interaction site formed by the physical association of two distinct G protein-coupled receptors. This heteromerization is predominantly observed in the mammalian brain, particularly within the prefrontal cortex, where it plays a critical role in modulating cognitive functions and emotional responses (Viñals et al., 2015, Nature Neuroscience). Research has demonstrated that this specific interface is a key mediator of the cognitive impairments, such as memory loss, induced by delta-9-tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. When these receptors form a heterodimer, their signaling properties change; for instance, the complex can trigger G-protein signaling pathways that are distinct from those activated by the individual receptors alone (Galindo et al., 2018, Molecular Neurobiology). This makes the interface a significant therapeutic target for developing drugs that can block the negative cognitive effects of cannabinoids without interfering with their potential therapeutic benefits, such as pain relief. Furthermore, the CB1R-5HT2AR complex has been implicated in the pathophysiology of neuropsychiatric disorders like schizophrenia and anxiety, suggesting that its modulation could offer new avenues for treatment (Bagher et al., 2018, Frontiers in Pharmacology).

Other names

CB1-5-HT2A heteromerCB1R-5HT2AR complexCannabinoid-serotonin receptor heterodimerCB1-5HT2A receptor heterodimer

The interface facilitates allosteric crosstalk between CB1R and 5HT2AR, leading to biased signaling and G-protein coupling shifts (e.g., from Gi to Gq) that mediate specific behavioral responses like memory impairment (Viñals et al., 2015, Nature Neuroscience; Galindo et al., 2018, Molecular Neurobiology).